Mascoma Wealth Management’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.7M Buy
226,552
+12,573
+6% +$1.01M 3.47% 8
2026
Q1
$16.2M Buy
213,979
+37,359
+21% +$2.92M 3.35% 8
2025
Q4
$13.2M Buy
176,620
+4,785
+3% +$357K 2.84% 10
2025
Q3
$12.6M Buy
171,835
+7,690
+5% +$552K 2.79% 10
2025
Q2
$11.6M Buy
164,145
+11,173
+7% +$745K 2.7% 10
2025
Q1
$9.75M Buy
+152,972
New +$9.58M 2.43% 10

Other funds holding JIRE

Mascoma Wealth Management's JIRE Position: Q2 2026 in Review

Mascoma Wealth Management increased its JPMorgan International Research Enhanced Equity ETF (JIRE) stake by 5.9% in Q2 2026, buying an estimated $1.01M and bringing the position to 226,552 shares worth $18.7M. The position accounts for 3.47% of the portfolio, ranked #8.

Mascoma Wealth Management first reported a position in JIRE in Q1 2025 and has held it in 6 quarters since. 350 funds tracked by Wall St. Rank hold JIRE as of Q2 2026.

  • Mascoma Wealth Management held 226,552 shares of JPMorgan International Research Enhanced Equity ETF worth $18.7M as of Q2 2026.
  • Mascoma Wealth Management bought 12,573 JPMorgan International Research Enhanced Equity ETF shares in Q2 2026, an estimated $1.01M.
  • JPMorgan International Research Enhanced Equity ETF made up 3.47% of Mascoma Wealth Management's portfolio in Q2 2026, its #8 holding.
  • Mascoma Wealth Management first reported a position in JPMorgan International Research Enhanced Equity ETF in Q1 2025 and has held it in 6 quarters since.
  • 350 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q2 2026.

Based on Mascoma Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.